ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "CLEAR Outcomes Subanalysis"
Episode Synopsis
Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins.
More episodes of the podcast Talking Points
The 2024 ESC CCS Guidelines
17/12/2025
The My Heart Your Heart Trial
10/12/2025
The FAVOR III Europe Trial
03/12/2025
The FLOW Trial
03/12/2025
STORM-PE TRIAL
19/11/2025
The EARLY TAVR and TAVR UNLOAD Trials
12/11/2025
The EPIC-CAD Trial
29/10/2025
The ECLIPSE Trial
01/10/2025
The CLEAR SYNERGY (OASIS 9) Trial
17/09/2025
The NOTION-3 Trial
03/09/2025
In God we trust